Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oral liquid alendronate formulations

Oral liquid alendronate formulations

US Patent 5462932 · Granted Oct 31, 1995

Estimated economic value: $150,897,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Solid forms and combination compositions comprising a beta-lactamase inhibitor a2025
Solid forms and combination compositions comprising a beta-lactamase inhibitor a2023
Method of administering amantadine prior to a sleep period2021
Solid forms and combination compositions comprising a beta-lactamase inhibitor a2021
Method of administering amantadine prior to a sleep period2018
Method of administering amantadine prior to a sleep period2018
Method of administering amantadine prior to a sleep period2018
Method of administering amantadine prior to a sleep period2018
Method of administering amantadine prior to a sleep period2014
Compressed tablet formulation2009
Patient oriented point of care system and method2009
Compressed tablet formulation2006